Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology Group
about
A c-Myc-regulated stem cell-like signature in high-risk neuroblastoma: A systematic discovery (Target neuroblastoma ESC-like signature).The pre-rRNA processing factor DEF is rate limiting for the pathogenesis of MYCN-driven neuroblastoma.Clinical characteristics and outcome of patients with neuroblastoma presenting genomic amplification of loci other than MYCN.PBX1 is a favorable prognostic biomarker as it modulates 13-cis retinoic acid-mediated differentiation in neuroblastoma.STAT3 inhibition suppresses proliferation of retinoblastoma through down-regulation of positive feedback loop of STAT3/miR-17-92 clusters.Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology GroupThe genetics of splicing in neuroblastoma.Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth in miceCase report: value of gene expression profiling in the diagnosis of atypical neuroblastoma.Neuroblastoma in children: Update on clinicopathologic and genetic prognostic factors.Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance.Downregulation of c-Myc is involved in TLR3-mediated tumor death of neuroblastoma xenografts.Advancing Clinicopathologic Diagnosis of High-risk Neuroblastoma Using Computerized Image Analysis and Proteomic Profiling.Aurora kinase A is a possible target of OSU‑03012 to destabilize MYC family proteins.Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group study.Immunohistochemical Profile of MYC Protein in Pediatric Small Round Blue Cell Tumors.Zebrafish as a model to study neuroblastoma development.MYC-family protein overexpression and prominent nucleolar formation represent prognostic indicators and potential therapeutic targets for aggressive high-MKI neuroblastomas: a report from the children’s oncology group.Dual BRD4 and AURKA Inhibition Is Synergistic against MYCN-Amplified and Nonamplified NeuroblastomaInnate immune sensor laboratory of genetics and physiology 2 suppresses tumor cell growth and functions as a prognostic marker in neuroblastoma
P2860
Q33669451-84F864D6-7679-4CD7-9378-18A61A302C34Q33884719-6075CC1C-8713-4824-AE81-2BA95AAC7599Q33889856-0EFAE897-1F35-40AF-AFC2-389CCE54F2D9Q34052920-B0FC9A8F-6C18-48E1-A232-6AA450B74E2DQ34957390-7D832B0D-4F75-4372-B1E7-EDAA9F78DB68Q35122169-D842C4AD-C3DF-4544-8B00-A03D6FBBECA9Q35328703-21B3EBB5-BBDB-483F-9705-CBCFF84ACC5AQ36175385-95766417-B0A4-42F7-9C57-07D451D48A37Q38619616-2AB796E9-37F2-4FCF-A6A8-4E084A637507Q38702196-14A06DFE-F189-47BC-81AA-10249C31C39AQ38716908-63A180E1-B9AE-40C7-AEE7-083449611CF0Q38770676-2FCD9432-A2FF-4BD9-AEB7-B858E8B3CCEFQ38831708-6F60EC04-D236-43FC-B2FE-E8CAC3DA7BA7Q38975838-F546F224-384A-49EA-AD2C-A185C3AD7D31Q40877769-7D99E432-574D-4E6B-8802-8122F1765010Q46520241-D44ED5B5-4FF8-4415-A5FF-64399E213117Q47899604-0230BF51-51A7-434B-8BC2-EF8E90036153Q50019647-9155DA14-DBA0-4811-ACF3-F6790BECE22DQ58702896-1EA1F6FB-12D3-4309-9CF1-D31933D9F04CQ58783846-D3D72F58-EC96-4C12-991E-5CE36044CA9B
P2860
Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology Group
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Neuroblastoma of undifferentia ...... the Children's Oncology Group
@ast
Neuroblastoma of undifferentia ...... the Children's Oncology Group
@en
type
label
Neuroblastoma of undifferentia ...... the Children's Oncology Group
@ast
Neuroblastoma of undifferentia ...... the Children's Oncology Group
@en
prefLabel
Neuroblastoma of undifferentia ...... the Children's Oncology Group
@ast
Neuroblastoma of undifferentia ...... the Children's Oncology Group
@en
P2093
P2860
P356
P1433
P1476
Neuroblastoma of undifferentia ...... the Children's Oncology Group
@en
P2093
A Thomas Look
Arlene Naranjo
Hiroyuki Shimada
John M Maris
Julie M Gastier-Foster
Julie R Park
Larry L Wang
Michael D Hogarty
Naohiko Ikegaki
Patrick McGrady
P2860
P304
P356
10.1002/CNCR.28251
P407
P577
2013-07-30T00:00:00Z